EORTC Receptor and Biomarker Study Group Report: A Sandwich Enzyme-Linked Immunosorbent Assay for Vascular Endothelial Growth Factor in Blood and Tumor Tissue Extracts
Free accessResearch articleFirst published online April, 2000
EORTC Receptor and Biomarker Study Group Report: A Sandwich Enzyme-Linked Immunosorbent Assay for Vascular Endothelial Growth Factor in Blood and Tumor Tissue Extracts
A four-antibody sandwich enzyme-linked immunosorbent assay (ELISA) for vascular endothelial growth factor (VEGF) for application in blood (serum and plasma) and tumor tissue extracts was set up within the framework of the EORTC Receptor and Biomarker Study Group (RBSG). Polyclonal antibodies against VEGF165 were raised in chickens and rabbits, and used in a previously described assay format. The assay was validated and characterized for use in serum, plasma and tumor tissue extracts. The resulting VEGF ELISA was found to be specific for VEGF165 and VEGF121, the main isoforms of VEGF. The assay showed good precision and parallelism in serial dilutions of samples. The assay was not susceptible to interference by heterophilic antibodies because avian antibodies (duck anti-chicken and chicken anti-VEGF) were used in the pre-analyte stage and mammalian antibodies (rabbit anti-VEGF and goat anti-rabbit) in the post-analyte stage. In conclusion, a sensitive, robust and specific VEGF ELISA has been developed. Research into the prognostic value of VEGF employing this assay is currently underway.
KraftA., WeindelK., OchsA.Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease.Cancer1999; 85: 178–87.
8.
MaedaK., KangS.M., OnodaN.Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma.Cancer1999; 86: 566–71.
9.
JacobsenJ., RasmusonT., GrankvistK., LjungbergB.Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.J Urol2000; 163: 343–7.
10.
NeufeldG., CohenT., GengrinovitchS., PoltorakZ.Vascular endothelial growth factor (VEGF) and its receptors.FASEB J1999; 13: 9–22.
11.
LyttleD.J., FraserK.M., FlemingS.B., MercerA.A., RobinsonA.J.Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus.J Virol1994; 68: 84–92.
12.
VerheulH.M., HoekmanK., Luykx-de BakkerS.Platelet: transporter of vascular endothelial growth factor.Clin Cancer Res1997; 3: 2187–90.
13.
BanksR.E., ForbesM.A., KinseyS.E.Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.Br J Cancer1998; 77: 956–64.
14.
SalvenP., OrpanaA., JoensuuH.Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.Clin Cancer Res1999; 5: 487–91.
15.
GrebenschikovN., Geurts-MoespotA., De WitteH.A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols.Int J Biol Markers1997; 12: 6–14.
16.
GrebenschikovN., SweepF., GeurtsA.ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1).Int J Cancer1999; 81: 598–606.
17.
HennigC., RinkL., FaginU., JabsW.J., KirchnerH.The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs.J Immunol Methods2000; 235: 71–80.
18.
Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute.Eur J Cancer1980; 16: 1513–5.
19.
PolsonA.Isolation of IgY from the yolks of eggs by a chloroform polyethylene glycol procedure.Immunol Invest1990; 19: 253–8.
20.
PassingH., Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.J Clin Chem Clin Biochem1983; 21: 709–20.
21.
BablokW., PassingH., BenderR., SchneiderB.A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III.J Clin Chem Clin Biochem1988; 26: 783–90.
AnthonyF.W., EvansP.W., WheelerT., WoodP.J.Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins.Ann Clin Biochem1997; 34: 276–80.
24.
Vuorela-VepsalainenP., AlfthanH., OrpanaA., AlitaloK., StenmanU.H., HalmesmakiE.Vascular endothelial growth factor is bound in amniotic fluid and maternal serum.Hum Reprod1999; 14: 1346–51.
25.
RodriguezC.R., FeiD.T., KeytB., BalyD.L.A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma.J Immunol Methods1998; 219: 45–55.
26.
SchlaeppiJ.M., EppenbergerU., Martiny-BaronG., KungW.Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates.Clin Chem1996; 42: 1777–84.
27.
EppenbergerU., KuengW., SchlaeppiJ.M.Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.J Clin Oncol1998; 16: 3129–36.
28.
WynendaeleW., DeruaR., HoylaertsM.F.Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?Ann Oncol1999; 10: 965–71.
29.
BoscatoL.M., StuartM.C.Incidence and specificity of interference in two-site immunoassays.Clin Chem1986; 32: 1491–5.
30.
BoscatoL.M., StuartM.C.Heterophilic antibodies: a problem for all immunoassays.Clin Chem1988; 34: 27–33.
31.
LarssonA., Karlsson-ParraA., SjoquistJ.Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors.Clin Chem1991; 37: 411–4.
32.
WheelerT., EvansP.W., AnthonyF.W., GodfreyK.M., HoweD.T., OsmondC.Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth.Hum Reprod1999; 14: 1619–23.
